ENOUGH

📍 Glasgow, United Kingdom🗓 Founded 2015👥 53 employees💰 Last funded Apr 2018
Biotechnology Research
LinkedIn
ENOUGHs purpose to ‘make protein sustainable’. Using fermentation to meet future food protein needs is widely recognised as the most effective solution to feed a growing planet. ENOUGH produces ABUNDA® mycoprotein, a complete food ingredient containing all essential amino acids as well as being high in dietary fibre. It is versatile and can be made into alternative/vegan meat, seafood and dairy products. The company will supply ABUNDA as a B2B (business to business) food ingredient to consumer brands and retailers, addressing the need for high scale supply of healthy and sustainable protein to address a rapidly growing market. The impact of introducing 1 million tonnes of ABUNDA mycoprotein by 2032 is equivalent to replacing 5 million cows, over a 1 billion chickens and reducing more than 5 million tonnes of CO2 emissions.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in ENOUGH?
ENOUGH has 1 investors on record on gritt.io, 1 mid-stage.
When did ENOUGH last raise funding?
The most recent investment in ENOUGH recorded on gritt.io was in April 2018.
When was ENOUGH founded?
ENOUGH was founded in 2015.
What industry is ENOUGH in?
ENOUGH operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ENOUGH based?
ENOUGH is headquartered in Glasgow, United Kingdom.